1. Home
  2. EXPI vs STOK Comparison

EXPI vs STOK Comparison

Compare EXPI & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eXp World Holdings Inc.

EXPI

eXp World Holdings Inc.

HOLD

Current Price

$9.03

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$31.74

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPI
STOK
Founded
2008
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
EXPI
STOK
Price
$9.03
$31.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
9
Target Price
$12.00
$33.11
AVG Volume (30 Days)
980.2K
875.5K
Earning Date
02-19-2026
11-04-2025
Dividend Yield
2.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.68
Revenue
$4,678,653,000.00
$205,632,000.00
Revenue This Year
$6.03
$430.24
Revenue Next Year
$5.37
N/A
P/E Ratio
N/A
$46.47
Revenue Growth
5.12
1128.17
52 Week Low
$6.90
$5.35
52 Week High
$12.23
$38.69

Technical Indicators

Market Signals
Indicator
EXPI
STOK
Relative Strength Index (RSI) 25.25 51.79
Support Level $9.55 $31.00
Resistance Level $9.94 $33.90
Average True Range (ATR) 0.29 1.67
MACD -0.12 -0.26
Stochastic Oscillator 4.80 17.61

Price Performance

Historical Comparison
EXPI
STOK

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: